Skip to content

PHI GROUP, INC.: 10-Q filed 2025-02-19

What PHI GROUP, INC. reported in its quarterly report filed 2025-02-19 (fiscal Q2 2025): 27 published measures, 79 facts as tagged in accession 0001493152-25-007556.

This filing

Form
10-Q (quarterly report)
Filed
2025-02-19
Fiscal period
fiscal Q2 2025
Accession
0001493152-25-007556 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PHI GROUP, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2024-12-3139,843USD
At 2024-06-3090,856USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2024-12-3111,520,177USD
At 2024-06-309,744,823USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2024-12-31-11,480,334USD
At 2024-09-30-10,611,773USD
At 2024-06-30-9,653,967USD
At 2024-03-31-8,936,654USD
At 2023-12-31-8,546,330USD
At 2023-09-30-8,540,992USD
At 2023-06-308,222,002USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2024-12-31310USD
At 2024-06-30303USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2024-10-01 to 2024-12-31-949,315USD92
2024-07-01 to 2024-12-31-2,025,989USD184
2023-10-01 to 2023-12-31-1,711,938USD92
2023-07-01 to 2023-12-31-4,701,841USD184

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2024-07-01 to 2024-12-31-1,790,818USD184
2023-07-01 to 2023-12-31-1,507,409USD184

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2023-10-01 to 2023-12-315,000USD92
2023-07-01 to 2023-12-315,000USD184

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2024-07-01 to 2024-12-311,790,825USD184
2023-07-01 to 2023-12-311,517,086USD184

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2024-12-31-87,540,740USD
At 2024-06-30-85,514,751USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2024-10-01 to 2024-12-3144,840,792,806shares92
2024-07-01 to 2024-12-3144,840,792,806shares184
2023-10-01 to 2023-12-3142,675,273,063shares92
2023-07-01 to 2023-12-3142,675,272,063shares184

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2024-10-01 to 2024-12-3144,840,792,806shares92
2024-07-01 to 2024-12-3144,840,792,063shares184
2023-10-01 to 2023-12-3142,675,273,063shares92
2023-07-01 to 2023-12-3142,675,272,063shares184

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2024-10-01 to 2024-12-310USD/shares92
2024-07-01 to 2024-12-310USD/shares184
2023-10-01 to 2023-12-310USD/shares92
2023-07-01 to 2023-12-310USD/shares184

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2024-10-01 to 2024-12-310USD/shares92
2024-07-01 to 2024-12-310USD/shares184
2023-10-01 to 2023-12-310USD/shares92
2023-07-01 to 2023-12-310USD/shares184

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2024-10-01 to 2024-12-31-146,464USD92
2024-07-01 to 2024-12-31-317,714USD184
2023-10-01 to 2023-12-31-181,692USD92
2023-07-01 to 2023-12-31-427,423USD184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2024-12-318,643USD
At 2024-06-3058,636USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2024-12-3111,520,177USD
At 2024-06-309,744,823USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2024-12-31628,120USD
At 2024-06-30626,730USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2024-10-01 to 2024-12-31146,464USD92
2024-07-01 to 2024-12-31317,714USD184
2023-10-01 to 2023-12-31186,692USD92
2023-07-01 to 2023-12-31432,423USD184

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2024-12-3146,873,940,565shares
At 2024-06-3046,873,940,565shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2024-12-31-1,937,163USD
At 2024-06-30-1,936,201USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2024-12-311,983,283USD
At 2024-06-301,795,874USD

Current contract liabilities

Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.

PeriodValueUnitDays
At 2024-12-31948,964USD
At 2024-06-30952,650USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2024-10-01 to 2024-12-3164,513USD92
2024-07-01 to 2024-12-31157,108USD184
2023-10-01 to 2023-12-31114,412USD92
2023-07-01 to 2023-12-31303,688USD184

Nonoperating interest expense

Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.

PeriodValueUnitDays
2024-10-01 to 2024-12-3141,735USD92
2024-07-01 to 2024-12-3183,470USD184
2023-10-01 to 2023-12-31236,624USD92
2023-07-01 to 2023-12-31280,300USD184

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2024-10-01 to 2024-12-31-802,851USD92
2024-07-01 to 2024-12-31-1,708,275USD184
2023-10-01 to 2023-12-31-1,530,246USD92
2023-07-01 to 2023-12-31-4,274,418USD184

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2024-07-01 to 2024-12-31200,583USD184
2023-07-01 to 2023-12-311,105,888USD184

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2024-07-01 to 2024-12-311,390USD184
2023-07-01 to 2023-12-312,120USD184

Inspect the source

Entity
PHI GROUP, INC. / CIK 0000704172
Captured
2026-09-21T17:17:07.527Z
SEC response SHA-256
06d02e746e46cfa426f867a35382147bf4cf591948e92cca1e9a109d36a66307

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000704172.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))